Literature DB >> 3759377

Serum thymidine kinase levels in cancer patients.

K L O'Neill, W P Abram, P G McKenna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3759377     DOI： 10.1007/bf02939884

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  5 in total

1.  Thymidine kinase in rat tissues during growth and differentiation.

Authors:  R Machovich; O Greengard
Journal:  Biochim Biophys Acta       Date:  1972-12-29

2.  Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue.

Authors:  H L Gordon; T J Bardos; Z F Chmielewicz; J L Ambrus
Journal:  Cancer Res       Date:  1968-10       Impact factor: 12.701

3.  Alteration of the activity and molecular from of thymidine kinase during development and aging in the mouse cerebellum.

Authors:  P C Caron; B R Unsworth
Journal:  Mech Ageing Dev       Date:  1978-09       Impact factor: 5.432

4.  The thymidine-kinase locus of Friend erythroleukaemic cells. 1. Mutation rates and properties of mutants.

Authors:  P G McKenna; I Hickey
Journal:  Mutat Res       Date:  1981-01       Impact factor: 2.433

5.  Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease.

Authors:  W Kreis; Z Arlin; A Yagoda; B R Leyland-Jones; L Fiori
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701
  5 in total
  5 in total

1.  Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings.

Authors:  Yan Chen; Mingang Ying; YanSong Chen; Minhua Hu; Yingying Lin; Dedong Chen; Xiaoli Li; Ming Zhang; Xia Yun; Ji Zhou; Ellen He; Sven Skog
Journal:  Int J Clin Oncol       Date:  2010-04-01       Impact factor: 3.402

2.  Comparison of plasma and tissue thymidine kinase activities.

Authors:  R J Calvert; S Satchithanandam
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

3.  Thymidine kinase in breast cancer.

Authors:  J F Robertson; K L O'Neill; M W Thomas; P G McKenna; R W Blamey
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

4.  Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.

Authors:  Evita G Weagel; Wei Meng; Michelle H Townsend; Edwin J Velazquez; Rachel A Brog; Michael W Boyer; K Scott Weber; Richard A Robison; Kim L O'Neill
Journal:  Onco Targets Ther       Date:  2017-09-06       Impact factor: 4.147

5.  Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.

Authors:  P G McKenna; K L O'Neill; W P Abram; B M Hannigan
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.